IL1B and chronic kidney disease: Apart from classical inflammatory cytokines (such as TNF, IL1, or IL6), new markers of inflammation have arisen as important pathogenic mediators for the progression of chronic kidney disease in diabetes (i.e., IL-1 beta, caspase 1-dependent NLRP3) [13].